Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 21 Neurofibromatosis 1 19 Neurofibroma, Plexiform 11 Melanoma 11 Lung Neoplasms 8 Neoplasms 7 Neoplasm Metastasis 7 Colorectal Neoplasms 7 Breast Neoplasms 7 Solid Tumours 5 Pancreatic Neoplasms 5 Carcinoma, Hepatocellular 4 Uveal Melanoma 3 Triple Negative Breast Neoplasms 3 Thyroid Neoplasms 3 Rectal Neoplasms 3 Neurofibrosarcoma 3 Gallbladder Neoplasms 3 Colonic Neoplasms 3 Biliary Tract Neoplasms 3 Thyroid Cancer, Papillary 2 Sarcoma 2 Bile Duct Neoplasms 2 Adult Solid Neoplasm 2 Thyroid Diseases 1 Thymoma 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Kaposi 1 Renal Insufficiency 1

Interventions

Nivolumab 20 Ipilimumab 10 Surveys and Questionnaires 7 Paclitaxel 7 linrodostat 6 Standard of Care 6 Sirolimus 5 Gemcitabine 5 Bevacizumab 5 temsirolimus 4 relatlimab 4 Pemetrexed 4 Interviews as Topic 4 Docetaxel 4 Carboplatin 4 ARRY-334543 4 Vorinostat 3 Erlotinib Hydrochloride 3 Dasatinib 3 Cetuximab 3 regorafenib 2 olaparib 2 apatinib 2 anlotinib 2 abemaciclib 2 Trastuzumab 2 Sunitinib 2 Sorafenib 2 Olanzapine 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancer × AZD 6244 × Clear all

NCT00085787 2020-10-14

A Study of ARRY-142886 in Patients With Advanced Cancer

Array BioPharma

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡